Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Drug
MicuRx Pharmaceuticals Concludes US Phase I Study for MRX-8
February 2, 2025
Company
Drug
Henlius Biotech’s Hanbeitai Approved for Hepatocellular Carcinoma
February 2, 2025
Company
Drug
Antengene’s Xpovio Receives Taiwan FDA Approval for Multiple Indications
February 2, 2025
Company
Drug
AIM Vaccine Receives CDE Approval for Serum-Free Rabies Vaccine Trial
February 2, 2025
Company
Deals
Rici Healthcare to Acquire Unicorn II Holdings for RMB 180M
February 2, 2025
Company
Roche Reports Q3 Sales Growth, Hit by COVID-19 Product Decline
February 2, 2025
Company
Ambrx Biopharma Halts Development of HER2 ADC ARX788, Cuts Workforce
February 2, 2025
Drug
R&D
Sinopharm’s Wuhan Institute Isolates Monkeypox Strains, Begins Vaccine Research
February 2, 2025
Company
Deals
CATUG Biotechnology Partners with Duoning to Advance mRNA Industrialization
February 2, 2025
Policy / Regulatory
Fujian Procurement Center Announces VBP for Cardiac and Laparoscopic Medical Consumables
February 2, 2025
Policy / Regulatory
NMPA Releases 61st Batch of Reference Drugs for Generic Quality Consistency Evaluation
February 2, 2025
Company
Drug
Betta Pharmaceuticals’ BPI-460372 Accepted for Clinical Trial Review by NMPA
February 2, 2025
1
2
…
1,112
1,113
1,114
1,115
1,116
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?